However, despite the promising results obtained with minocycline in several animal models of inflammatory disorders, pilot studies in HIV-infected individuals have yet to yield significant changes in inflammatory markers such as neopterin, CCL2, or cognitive impairment [97], [120], [121]. This evidence concerns the gene CCL2 and Cognitive impairment.